English - Uhthoff


The industrial and economic development that globally has occurred since the last century, has generated an important impact not only related to companies’ commercial growth, but also related to the generation of intangible business assets which without being expected, have been acquiring greater value and  commercial recognition in the industry, generating competition between companies and their different manufactured products […]

Regulatory Certainty Strategy for Biosimilar Drugs in Mexico

Mexico has been continuously facing the new challenges related to the growing biotechnology industry. Mexican authorities have recognized that the current regulation does not generate the ideal conditions to allow the effective entry (from the clinical phase to obtaining marketing authorizations) of new innovative treatments, biosimilars or interchangeable generics. Since November 2021, Mexico was accepted […]

Accelerated Patent Grant (AGP) agreement between IMPI-USPTO as a new complement for optimizing patent prosecution in Mexico.

Mexican Institute of Industrial Property (IMPI) has been focusing efforts in reducing timeframe for patent prosecution in Mexico, considering available foreign work products, efforts, and analysis. Increasing the possibilities for applicants to accelerate patent prosecution time takes high relevance when considering the provision of Article 126 of Federal Law for Protection of Industrial Property (FLPIP), […]


  At the end of 2022, a new artificial intelligence chatbot was launched and quickly went viral: ChatGPT. The chatbot created by OpenAI was originally supposed to provide support for online customer service, but it exceeded all the expectations.   If you ask directly to ChatGPT, it will answer that its “main function is to […]

If you are concerned with the granting of sanitary registrations to generic medicaments, this might be of interest to you

This to inform you about recent developments concerning the request and obtention of Sanitary Registrations (SR) -which is the authorization needed in Mexico for a medicament to be granted access to consumers-, specifically of those medicaments involving patent-protected pharmaceutical compounds, i.e., active pharmaceutical ingredient (API).   In this sense we are glad to announce the […]

Challenges of Intellectual Property Laws Posed by 3D Printing

3D printing, also referred to as additive manufacturing, is a process of creating solid objects from any file (3dprinting.com, n.d.). The main difference between conventional manufacturing and 3D printing is that this new process entails adding thin layers of diverse sizes to form the object that the files contain, while the conventional process involves cutting […]

Mexican Institute of Industrial Property (IMPI) and European Patent Office (EPO) strategic cooperation enhancing patent-prosecution strategies in Mexico in terms of pharmaceutical patents.

Mexico is the leading country in exports of pharmaceutical products in Latin-American. The pharmaceutical sector in Mexico is considered one of the top ten industries interested in patent protection for its products, processes or uses. From the available current data of the IMPI and World Intellectual Property Organization (WIPO), the main technical field of filed […]


Industrial Designs constitute the ornamental or aesthetic aspect of an article. In accordance with the Mexican Federal Law for the Protection of Industrial Property (LFPPI), Industrial Designs that are new and susceptible to industrial application will be registrable. In Mexico, Industrial Designs include: 1.- Industrial Drawings, which are any combination of figures, lines or colors […]

Artificial Intelligence and Patent Law: Navigating the Landscape in 2023

AI (Artificial Intelligence) is much more than stories of robots that look and sound like humans. In fact, until today, no technology is remotely close to approach the ability of a human. No machine with self sustaining long-term goals has been developed and it is not likely to be developed in the near future. Yet, […]